Globe Badania Klinicznesp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-06-01
Share capital
21,000.00 PLN
Registered address
ul. Janusza Kusocińskiego 3A, 57-300 Kłodzko, Poland
Electronic delivery address
AE:PL-54320-15300-RGFSW-26

Financials

Data for 2025 is not shown: the filed document has no balance sheet and its profit and loss account is unreadable.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 29%
Voivodeship · Dolnośląskie17,048 / 41,331
Top 41%
Country · Poland212,698 / 495,850
Top 43%

Results vs industry

Revenue
This companyUSD 283.65kMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 93.43kMedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 182.10kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 120.63kMedianUSD 119.88kAverageUSD 3.90m

Authorized Representatives

Anna Agnieszka Jachna – President of the Management Board
Mateusz Michał Wolfson – Vice President of the Management Board

Manner of representation

In the case of a multi-member management board, each member of the management board is authorised to submit declarations of will on behalf of the company independently; however, the disposal of a right or the incurring of obligations to make a payment exceeding PLN 50,000.00 (fifty thousand zlotys) requires the action of two members of the management board or of a member of the management board and a commercial proxy.

Ownership

OwnerSharesShare valueStake
Fundacja Rodzinna Edyty i Mateusza Wolfson w Organizacji
70$945.4316.6667%
Fundacja Rodzinna Teresy & Wiktora Wolfsonów w Organizacji
70$945.4316.6667%
Anna Agnieszka Jachnaage 52
70$945.4316.6667%
Agnieszka Jadczakage 53
70$945.4316.6667%
Others
140$1,890.8733.3332%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2015-10-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

17 public aid cases recorded, with a total value of $47,726.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Other crisis aid
–

Change history

DateEvent
2018-08-09Share capital increase
2015-06-01Entered in the register

FAQ

Last updated: 2026-09-17